Insider · CIK 0001834161
Mark Eisner
officer
Files at VIR (Vir Biotechnology, Inc.). First filing Jul 17, 2025, latest Jul 17, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $57k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VIR: Vir Biotechnology, Inc.
VIROct 9, 2026 · close 11.70
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | Vir Biotechnology, Inc. | $57k 10,382 shares | -9% | +18% from low-58% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 15, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stock10b5-1 | -6,796 | $5.47 | $37k | 108,204 | Jul 17, 2025 |
| Jul 17, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stock10b5-1 | -3,586 | $5.47 | $20k | 104,618 | Jul 17, 2025 |
| Feb 22, 2025 | VIR Vir Biotechnology, Inc. | AGrant or award Common Stock10b5-1 | +40,000 | $0.00 | $0 | 115,000 | Feb 25, 2025 |
| Feb 22, 2025 | VIR Vir Biotechnology, Inc. | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +80,000 | $0.00 | $0 | 80,000 | Feb 25, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.